A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer (Q33340265)
scientific article published on December 1, 2001
Language:
(P31) (Q13442814)
(P304) 3920-3927
(P407) (Q1860)
(P433) 12
(P478) 7
(P577) Saturday, December 1, 2001
Saturday, December 1, 2001
(P921) (Q181257)
(P953) http://clincancerres.aacrjournals.org/cgi/content/abstract/7/12/3920
(P1433) (Q332253)
(P1476) "A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer" (language: en)
(P2093) K. N. Chi
M. E. Gleave
R. Klasa
N. Murray
C. Bryce
D. E. Lopes de Menezes
S. D'Aloisio
A. W. Tolcher
other details
description scientific article published on December 1, 2001

External Links